Bone and Blood Interactions in Human Health and Disease

Overview

Journal Bone

Specialties Endocrinology
Orthopedics

Date 2018 Feb 25

PMID 29476979

Citations 22

Authors

Rodrigo J Valderrabano

Joy Y Wu

Affiliations

Soon will be listed here.

Abstract

Under physiologic conditions hematopoiesis takes place in the bone marrow, and the skeleton provides the structural and supportive network necessary for normal hematopoiesis. Chronic disorders affecting hematopoiesis such as sickle cell anemia and thalassemia demonstrate striking skeletal phenotypes including bone loss and increased fracture risk. There is mounting evidence that anemia in older populations may also be associated with bone fragility. Given the interconnectedness of bone and hematopoietic cells, it is important to review the potential clinical implications and opportunities for therapeutic intervention. There are recognized associations between blood-borne and solid tissue malignancy and skeletal health, but our review will focus on non-malignant disease.

Citing Articles

Diagnosis Osteoporosis Risk: Using Machine Learning Algorithms Among Fasa Adults Cohort Study (FACS).

Tabib S, Alizadeh S, Andishgar A, Pezeshki B, Keshavarzian O, Tabrizi R Endocrinol Diabetes Metab. 2025; 8(1):e70023.

PMID: 39760233 PMC: 11702405. DOI: 10.1002/edm2.70023.

Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.

Adesina O, Jenkins I, Galvao F, de Moura A, Fertrin K, Zemel B Osteoporos Int. 2024; 36(1):93-102.

PMID: 39433652 PMC: 11706892. DOI: 10.1007/s00198-024-07268-1.

Bone turnover, areal BMD, and bone microarchitecture by second-generation high-resolution peripheral quantitative computed tomography in transfusion-dependent thalassemia.

Das L, Khadwal A, Malhotra P, Ghosh J, Dhiman V, Sharma V JBMR Plus. 2024; 8(11):ziae117.

PMID: 39372604 PMC: 11450324. DOI: 10.1093/jbmrpl/ziae117.

Osteoporosis treatment: current drugs and future developments.

Chen Y, Jia L, Han T, Zhao Z, Yang J, Xiao J Front Pharmacol. 2024; 15:1456796.

PMID: 39188952 PMC: 11345277. DOI: 10.3389/fphar.2024.1456796.

Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia.

Ananvutisombat N, Tantiworawit A, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T Front Endocrinol (Lausanne). 2024; 15:1393865.

PMID: 38978629 PMC: 11228236. DOI: 10.3389/fendo.2024.1393865.

References

Ricci C, Cova M, Kang Y, Yang A, Rahmouni A, Scott Jr W . Normal age-related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology. 1990; 177(1):83-8. DOI: 10.1148/radiology.177.1.2399343. View

Merriman N, Putt M, Metz D, Yang Y . Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology. 2009; 138(4):1330-7. PMC: 2954457. DOI: 10.1053/j.gastro.2009.12.007. View

Silva D, Coelho A, Dumke A, Valentini J, de Nunes J, Stefani C . Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care. 2011; 56(7):961-8. DOI: 10.4187/respcare.01056. View

Mahachoklertwattana P, Pootrakul P, Chuansumrit A, Choubtum L, Sriphrapradang A, Sirisriro R . Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes. J Bone Miner Metab. 2006; 24(2):146-52. DOI: 10.1007/s00774-005-0661-0. View

Mellstrom D, Johnell O, Ljunggren O, Eriksson A, Lorentzon M, Mallmin H . Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res. 2006; 21(4):529-35. DOI: 10.1359/jbmr.060110. View

Yu E, Kumbhani R, Siwila-Sackman E, DeLelys M, Preffer F, Leder B . Teriparatide (PTH 1-34) treatment increases peripheral hematopoietic stem cells in postmenopausal women. J Bone Miner Res. 2014; 29(6):1380-6. PMC: 4564394. DOI: 10.1002/jbmr.2171. View

Gurkan U, Akkus O . The mechanical environment of bone marrow: a review. Ann Biomed Eng. 2008; 36(12):1978-91. DOI: 10.1007/s10439-008-9577-x. View

Singbrant S, Russell M, Jovic T, Liddicoat B, Izon D, Purton L . Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood. 2011; 117(21):5631-42. DOI: 10.1182/blood-2010-11-320564. View

McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View

10.

Cazzola M, De Stefano P, Ponchio L, Locatelli F, Beguin Y, Dessi C . Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. Br J Haematol. 1995; 89(3):473-8. DOI: 10.1111/j.1365-2141.1995.tb08351.x. View

11.

Hiram-Bab S, Liron T, Deshet-Unger N, Mittelman M, Gassmann M, Rauner M . Erythropoietin directly stimulates osteoclast precursors and induces bone loss. FASEB J. 2015; 29(5):1890-900. DOI: 10.1096/fj.14-259085. View

12.

Cristy M . Active bone marrow distribution as a function of age in humans. Phys Med Biol. 1981; 26(3):389-400. DOI: 10.1088/0031-9155/26/3/003. View

13.

Toumba M, Skordis N . Osteoporosis syndrome in thalassaemia major: an overview. J Osteoporos. 2010; 2010:537673. PMC: 2957233. DOI: 10.4061/2010/537673. View

14.

Graat-Verboom L, van den Borne B, Smeenk F, Spruit M, Wouters E . Osteoporosis in COPD outpatients based on bone mineral density and vertebral fractures. J Bone Miner Res. 2010; 26(3):561-8. DOI: 10.1002/jbmr.257. View

15.

Compston J, Cooper A, Cooper C, Francis R, Kanis J, Marsh D . Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009; 62(2):105-8. DOI: 10.1016/j.maturitas.2008.11.022. View

16.

Guralnik J, Eisenstaedt R, Ferrucci L, Klein H, Woodman R . Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004; 104(8):2263-8. DOI: 10.1182/blood-2004-05-1812. View

17.

Paccou J, Hardouin P, Cotten A, Penel G, Cortet B . The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians. J Clin Endocrinol Metab. 2015; 100(10):3613-21. DOI: 10.1210/jc.2015-2338. View

18.

Klein H, Spahn D, Carson J . Red blood cell transfusion in clinical practice. Lancet. 2007; 370(9585):415-26. DOI: 10.1016/S0140-6736(07)61197-0. View

19.

Hwang S, Panicek D . Magnetic resonance imaging of bone marrow in oncology, Part 1. Skeletal Radiol. 2007; 36(10):913-20. DOI: 10.1007/s00256-007-0309-3. View

20.

Silva J, Moraes Z, Silva C, Mazon S, Guariento M, Neri A . Understanding red blood cell parameters in the context of the frailty phenotype: interpretations of the FIBRA (Frailty in Brazilian Seniors) study. Arch Gerontol Geriatr. 2014; 59(3):636-41. DOI: 10.1016/j.archger.2014.07.014. View